Regular Consultancy Days

Regular Consultancy Days

This month we have seen a massive uptake of practice consultancy days and I completely understand why – practice managers have this need to keep every plate spinning, this super-being who is an expert in HR, IT, finance, business development, facilities,...
Legacy Smartcard

Legacy Smartcard

This month there are changes to the smartcards used for signing electronic prescriptions. All relevant computers and devices must have the software Oberthur middleware installed. Middleware is the communications link between applications on a computer and the...
GLP-1 Notifications

GLP-1 Notifications

Judging by the number of private letters for patients commencing GLP-1 our coding team are getting currently, we imagine many of you are getting a bit bogged down by these.  The process we recommend is our coding team will add a code for anti-obesity medication...
PCA’s & Exceptions

PCA’s & Exceptions

There is still a lot of confusion around Personalised Care Adjustments (PCA’s) and Exceptions and when to use them.  PCA’s were introduced in April 2019, to differentiate  between adjusting care and removing a patient from a denominator. PCA’s are automatically...
Childhood Immunisations increased to £12.06

Childhood Immunisations increased to £12.06

To avoid confusion, the services listed below have increased from £10.06 to £12.06 per vaccine administered: Childhood Immunisations Hexavalent (6-in-1) vaccination programme 2025/28 (6IN125) HepB vaccination programme 2025/28 (HEPB25) Meningococcal B (MenB)...
Non-Diabetic Hyperglycaemia (NDH)

Non-Diabetic Hyperglycaemia (NDH)

NDH002 – % patients with NDH who have had a HbA1c or fasting glucose performed in the last 12m NDH or pre-diabetes is designed to intervene to prevent or delay the onset of type 2 diabetes. NDH has the fastest growing prevalence rate; 1.07% increase in the last...
Why do all items not appear on a FP34D Report?

Why do all items not appear on a FP34D Report?

If you add a code for administration of … and then add brand/manufacturer, it will not appear. For it to appear on the FP34D report it first needs to be added as a medicine to the patients acute list and have the box ticked for personally administered. This is really...